Profound Medical to Participate in the Stifel 2023 Healthcare Conference
November 08, 2023 07:45 ET
|
Profound Medical Corp.
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
November 03, 2023 08:00 ET
|
Profound Medical Corp.
TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Third Quarter 2023 Financial Results
November 02, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
October 19, 2023 16:30 ET
|
Profound Medical Corp.
TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
October 10, 2023 16:30 ET
|
Profound Medical Corp.
TORONTO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
September 25, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
September 21, 2023 08:00 ET
|
Profound Medical Corp.
TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023 16:45 ET
|
Profound Medical Corp.
TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
September 06, 2023 19:23 ET
|
Profound Medical Corp.
TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) announces that it has established an at-the-market equity program (the “ATM...
Profound Medical Announces Second Quarter 2023 Financial Results
August 09, 2023 16:05 ET
|
Profound Medical Corp.
TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...